A global survey of potential acceptance of a COVID-19 vaccine

Jeffrey V. Lazarus,Scott C. Ratzan,Adam Palayew,Lawrence O. Gostin,Heidi J. Larson,Kenneth Rabin,Spencer Kimball,Ayman El-Mohandes
DOI: https://doi.org/10.1038/s41591-020-1124-9
IF: 82.9
2020-10-20
Nature Medicine
Abstract:Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 61.4% reported that they would accept their employer's recommendation to do so. Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer's advice to do so.
biochemistry & molecular biology,cell biology,medicine, research & experimental
What problem does this paper attempt to address?